SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-22-005064
Filing Date
2022-07-21
Accepted
2022-07-21 14:55:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT pharmacyte_8k.htm DEFA14A 20534
2 PRESS RELEASE pharmacyte_ex9901.htm EX-99.1 13776
3 GRAPHIC image_001.jpg GRAPHIC 3752
  Complete submission text file 0001683168-22-005064.txt   40815
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: DEFA14A | Act: 34 | File No.: 001-40699 | Film No.: 221096842
SIC: 2836 Biological Products, (No Diagnostic Substances)